Presbyterian Medical Services Santa Fe Community Guidance Center
-
Services:
- Treatment for other addiction disorder
- Female
- Male
- Prescribes buprenorphine
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Complete medical history/physical exam
- Screening for mental disorders
- Screening for tobacco use
- Interim services for clients
- Comprehensive substance use assessment
- Screening for substance use
- Comprehensive mental health assessment
- Outreach to persons in the community
- Assistance with obtaining social services
- Mentoring/peer support
- Housing services
- Sign language services for the deaf and hard of hearing
- Group counseling
- Marital/couples counseling
- Substance use disorder education
- Individual counseling
- Health education services other than HIV/AIDS or hepatitis
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- Family counseling
- HIV testing
- Testing for Hepatitis C (HCV)
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- STD testing
- Metabolic syndrome monitoring
- TB screening
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Seniors or older adults
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Vaping permitted in designated area
- Adults
- Young Adults
- Private non-profit organization
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Medicaid
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Medicare
- Federal, or any government funding for substance use treatment programs
- Outcome follow-up after discharge
- Naloxone and overdose education
- Discharge Planning
- Motivational interviewing
- Brief intervention
- Cognitive behavioral therapy
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Relapse prevention
- Anger management
- Contingency management/motivational incentives
- In-network prescribing entity
- Other contracted prescribing entity
- Smoking permitted in designated area
- Acamprosate (Campral®)
- Buprenorphine with naloxone
- Medications for Hepatitis C treatment
- Nicotine replacement
- Medication for mental disorders
- Clonidine
- Naltrexone (extended-release, injectable)
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Buprenorphine sub-dermal implant
- Buprenorphine without naloxone
- This facility administers/prescribes medication for alcohol use disorder
- Mental health services
- Suicide prevention services
- Case management service
- Social skills development
- Integrated primary care services
- State department of health
- SAMHSA certification for opioid treatment program (OTP)
- Federally Qualified Health Center
- Drug Enforcement Agency (DEA)
- State mental health department
- State Substance use treatment agency
- The Joint Commission
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
Other Services
Gender Accepted
Type of Opioid Treatment
Assessment/Pre-treatment
Recovery Support Services
Language Services
Education and Counseling Services
Testing
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Type of Care
Facility Vaping Policy
Age Groups Accepted
Facility Operation (e.g., Private, Public)
Opioid Medications used in Treatment
Payment/Insurance/Funding Accepted
Transitional Services
Treatment Approaches
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Smoking Policy
Pharmacotherapies
Type of Alcohol Use Disorder Treatment
Ancillary Services
License/Certification/Accreditation
Medical Services